IFG Advisory’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,414
Closed -$333K 710
2025
Q4
$333K Buy
2,414
+205
+9% +$26.8K 0.01% 610
2025
Q3
$283K Sell
2,209
-93
-4% -$11.3K 0.01% 650
2025
Q2
$279K Sell
2,302
-10,567
-82% -$1.19M 0.01% 629
2025
Q1
$1.43M Buy
12,869
+10,430
+428% +$1.11M 0.08% 262
2024
Q4
$237K Buy
+2,439
New +$260K 0.01% 600
2024
Q3
Sell
-2,310
Closed -$246K 542
2024
Q2
$246K Buy
+2,310
New +$232K 0.02% 549
2024
Q1
Sell
-3,369
Closed -$340K 507
2023
Q4
$340K Sell
3,369
-1,192
-26% -$115K 0.02% 448
2023
Q3
$465K Buy
+4,561
New +$463K 0.04% 358
2023
Q2
Sell
-18,404
Closed -$1.69M 444
2023
Q1
$1.69M Buy
18,404
+6,578
+56% +$574K 0.16% 158
2022
Q4
$1.07M Buy
11,826
+2,138
+22% +$180K 0.11% 200
2022
Q3
$736K Buy
+9,688
New +$803K 0.07% 258
2022
Q2
Sell
-2,360
Closed -$207K 513
2022
Q1
$207K Buy
2,360
+21
+0.9% +$1.82K 0.02% 468
2021
Q4
$204K Sell
2,339
-109
-4% -$9.05K 0.02% 478
2021
Q3
$200K Sell
2,448
-76
-3% -$6.84K 0.02% 470
2021
Q2
$230K Sell
2,524
-1,477
-37% -$132K 0.03% 433
2021
Q1
$342K Buy
4,001
+282
+8% +$25.3K 0.04% 372
2020
Q4
$351K Buy
3,719
+64
+2% +$5.59K 0.05% 327
2020
Q3
$317K Hold
3,655
0.05% 315
2020
Q2
$319K Buy
3,655
+29
+0.8% +$2.5K 0.06% 295
2020
Q1
$298K Sell
3,626
-18
-0.5% -$1.61K 0.07% 265
2019
Q4
$345K Hold
3,644
0.06% 291
2019
Q3
$316K Sell
3,644
-1,087
-23% -$97.6K 0.06% 292
2019
Q2
$432K Sell
4,731
-702
-13% -$59.4K 0.08% 220
2019
Q1
$468K Sell
5,433
-230
-4% -$18.5K 0.09% 206
2018
Q4
$435K Sell
5,663
-354
-6% -$27.6K 0.1% 190
2018
Q3
$464K Sell
6,017
-242
-4% -$17.9K 0.09% 219
2018
Q2
$423K Sell
6,259
-186
-3% -$12.8K 0.09% 220
2018
Q1
$466K Sell
6,445
-599
-9% -$45.6K 0.1% 191
2017
Q4
$529K Buy
+7,044
New +$531K 0.12% 170

Other funds holding NVS